CVE-2026-24217 Details
Description
NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.
A path traversal vulnerability has been identified in NVIDIA BioNeMo Core for Linux. This issue allows users to load malicious files, potentially leading to unauthorized code execution, denial of service, information disclosure, and data tampering. The vulnerability affects versions prior to a specific commit in the main branch.
Metrics
CVSS 4.0 Severity and Vector Strings:
No CVSS 4.0 data is available for this CVE.
CVSS 3.x Severity and Vector Strings:
No data available for CVSS Version 2.0 on this CVE.
CISA-ADP
Assessed May 20, 2026References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
| URL | Source(s) | Tag(s) |
|---|---|---|
| https://nvd.nist.gov/vuln/detail/CVE-2026-24217 | [email protected] | US Government Resource |
| https://nvidia.custhelp.com/app/answers/detail/a_id/5831 | [email protected] | Vendor Advisory |
| https://www.cve.org/CVERecord?id=CVE-2026-24217 | [email protected] | Third Party Advisory |
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| CWE-29 | Path Traversal: '\..\filename' | [email protected] |
Affected Products
| Product | Versions |
|---|---|
| nvidia bionemo framework | < 2026-04-03 |
CPE
Remediation
| |
| linux linux kernel | All versions |
CPE
Remediation
| |
Change History
5 change records found show changes
| Date | Action | Recorded By |
|---|---|---|
| Jul 23, 2026 | CVE Translated | [email protected] |
| Jun 17, 2026 | CVE Modified | [email protected] |
| Jun 17, 2026 | CVE Modified | CISA-ADP |
| May 21, 2026 | Initial Analysis | [email protected] |
| May 20, 2026 | New CVE Received | [email protected] |